Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
Giovanna Cocomazzi(Casa Sollievo della Sofferenza), Alessandra Mangia(Casa Sollievo della Sofferenza), Valeria Piazzolla(Casa Sollievo della Sofferenza), Francesco Giuliani(Ospedale San Paolo), Vincenzo Giambra(Casa Sollievo della Sofferenza), Alberto Maiorana(Casa Sollievo della Sofferenza), Stefano Antinucci(Casa Sollievo della Sofferenza), Maria Maddalena Squillante(Casa Sollievo della Sofferenza), Nicola Serra(Federico II University Hospital)
Cited by 15
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Neo-adjuvant and adjuvant chemotherapy of gastric cancer
|Annals of Oncology|2007|63
The Impact of the Female Genital Microbiota on the Outcome of Assisted Reproduction Treatments
|Microorganisms|2023|46
Hepatitis C virus micro-elimination: Where do we stand?
|World Journal of Gastroenterology|2021|26
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
|International Journal of Molecular Sciences|2024|23